Abstract
A multiconformational method for analyzing the biological activity of compounds is proposed that combines conformer search algorithms and a 3D‐QSAR receptor modeling procedure. The method allows one to find high‐activity and low‐activity conformers and determine the receptor shape. The biological activity of a substance is determined as a superposition of the activities of its conformers with allowance for their proportions in the substance. Agreement between calculated and experimental conformations and between calculated and experimental biological activities pIC 50%) is demonstrated by the example of agonists of the 5‐HT1A receptor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
H. Kubinyi, Drug Discov. Today, 2, 538-546 (1997).
F. Ooms, Curr. Med. Chem., 7, 141-158 (2000).
G. G. Wermuth, “Rational approaches to drug design," in: H. D. Holtje and W. Sippl. (eds.), Proc. of the 13th Europ. Symp. on Quantitative Structure-Activity Relationships, QSAR 2000 (Heinrich-Heine-Universität, Dusseldorf, Germany, August 27-September 1, 2000), Prous Science Publishers, Dusseldorf (2001), pp. 3-20.
M. Karelson, Molecular Descriptors in QSAR/QSPR, New York, Wiley and Sons (2000).
J. Zupan and J. Gasteiger, Neural Networks for Chemistry and Drug Design, Wiley-VCH, Weinheim, Germany (2000).
L. Piela, J. Kostrowicki, and H. A. Scheraga, J. Phys. Chem., 93, 3339-3346 (1989).
S. Schelstraete and H. Verschelde, J. Phys. Chem. A, 101, 310-315 (1998).
R. V. Pappu, R. K. Hart, and J. W. Ponder, J. Phys. Chem. B, 102, 9725-9742 (1998).
I. Andricioaei and J. E. Straub, J. Comput. Chem., 19, 1445-1455 (1998).
A. M. Doweyko, J. Med. Chem., 31, 1396-1406 (1988).
M. Santagati, H. M. Chen, A. Santagati, et al., in: K. Gundertofte and F. S. Jorgensen (eds.), Molecular Modelling and Prediction of Bioactivity, Kluwer Academic/Plenum Publishers, New York (2000), pp. 433-439.
V. A. Potemkin, E. V. Bartashevich, M. A. Grishina, and S. Guccione, “Rational approaches to drug design,” in: H. D. Holtje and W. Sippl (eds.), Proc. of the 13th Europ. Symp. on Quantitative Structure-Activity Relationships, QSAR 2000 (Heinrich-Heine-Universität, Dusseldorf, Germany, August 27-September 1, 2000), Prous Science Publishers, Dusseldorf (2001), pp. 349-353.
E. V. Bartashevich, V. A. Potemkin, M. A. Grishina, and A.V. Belik, Zh. Strukt. Khim., 43, No. 6, 1128-1133 (2000).
M. Modica, M. Santagati, F. Russo, et al., J. Med. Chem., 40, 574 (1997).
S. Guccione, A. M. Doweyko, H. M. Chen, et al., J. Comput-Aided Mol. Design, 14, 647-657 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Potemkin, V.A., Arslambekov, R.M., Bartashevich, E.V. et al. Multiconformational Method for Analyzing the Biological Activity of Molecular Structures. Journal of Structural Chemistry 43, 1045–1049 (2002). https://doi.org/10.1023/A:1023615231976
Issue Date:
DOI: https://doi.org/10.1023/A:1023615231976